Pavurutamab Biosimilar – Anti-TNFRSF17;CD3E mAb – Research Grade

Reference:
Product namePavurutamab Biosimilar - Anti-TNFRSF17;CD3E mAb - Research Grade
SourceCAS 2250292-39-6
SpeciesHumanized
Expression systemXtenCHO
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3 week if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsPavurutamab,AMG701, AMG-701, ANTI-BCMA X ANTI-CD3 BITE (BISPECIFIC T CELL ENGAGER) ANTIBODY CONSTRUCT,TNFRSF17;CD3E,anti-TNFRSF17;CD3E
ReferencePX-TA1700
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeBispecific scFv,Kappa;Lambda
ClonalityMonoclonal Antibody

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Pavurutamab Biosimilar – Anti-TNFRSF17;CD3E mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD269 / TNFRSF17, C-Fc, recombinant protein
Antigen CD269 / TNFRSF17, C-Fc, recombinant protein PX-P5605 385€
Stable Istotope Labelled Pavurutamab Biosimilar – Anti-TNFRSF17;CD3E mAb – Research Grade
SIL Stable Istotope Labelled Pavurutamab Biosimilar – Anti-TNFRSF17;CD3E mAb – Research Grade PX-TA1700-SIL 1500€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.